Sophiris Bio (SPHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,426 | -3,329 | -8,628 | -4,664 | -2,010 |
| Depreciation Amortization | 70 | 31 | 181 | 133 | 95 |
| Accounts payable and accrued liabilities | 436 | 299 | 374 | 254 | 41 |
| Other Working Capital | 1,574 | 615 | 68 | -211 | -591 |
| Other Operating Activity | -3 | -1,424 | -1,963 | -2,830 | -2,404 |
| Operating Cash Flow | $-7,349 | $-3,808 | $-9,968 | $-7,318 | $-4,869 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -2 | -3 | -3 | -1 |
| Purchase Of Investment | -2,081 | -1,091 | -15,835 | -8,683 | -5,400 |
| Sale Of Investment | 7,287 | 5,100 | 22,161 | 12,736 | 4,291 |
| Investing Cash Flow | $5,203 | $4,007 | $6,323 | $4,050 | $-1,110 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 6,930 | 6,953 | N/A |
| Common Stock Issued | N/A | N/A | 2 | 2 | 2 |
| Financing Cash Flow | $N/A | $N/A | $6,932 | $6,955 | $2 |
| Exchange Rate Effect | N/A | N/A | N/A | -1 | 1 |
| Beginning Cash Position | 16,087 | 16,087 | 12,800 | 12,800 | 12,800 |
| End Cash Position | 13,941 | 16,286 | 16,087 | 16,486 | 6,824 |
| Net Cash Flow | $-2,146 | $199 | $3,287 | $3,686 | $-5,976 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,349 | -3,808 | -9,968 | -7,318 | -4,869 |
| Capital Expenditure | -3 | -2 | -3 | -3 | -1 |
| Free Cash Flow | -7,352 | -3,810 | -9,971 | -7,321 | -4,870 |